The complement system in innate and adaptive immunity: normal functioning of the complement system
Prof. Steven Sacks King's College London, UK

Lewy body dementia
Prof. John-Paul Taylor Newcastle University, UK 

Hypersensitivity diseases: type II-IV hypersensitivity
Prof. Sara Marshall Wellcome Trust, UK

The basic epidemiology of tuberculosis (TB)
Dr. David Dowdy Johns Hopkins Bloomberg School of Public Health, USA 

The complement system in innate and adaptive immunity: diseases mediated by the complement system
Prof. Steven Sacks King's College London, UK

The genetics of stuttering
Dr. Dennis Drayna National Institute on Deafness and Other Communication Disorders, USA

Surveillance, prevention, and control of vector-borne diseases
Prof. Jonathan Day University of Florida, USA 

G proteins and the biology of depression and antidepressants
Prof. Mark M. Rasenick University of Illinois, USA

The pathogenesis of tuberculosis The pathogenesis of tuberculosis
Dr. William R. Bishai Johns Hopkins University School of Medicine, USA 

Roles of AMPK in energy homeostasis and nutrient sensing
Prof. Grahame Hardie University of Dundee, UK

Preclinical translation of mesenchymal stem cell therapies
Dr. Peter Childs University of Strathclyde, UK 

The End TB Strategy towards TB elimination
Dr. Mario Raviglione University of Milan, Italy

Development and regulation of cellular and gene therapy products: FDA perspective
Dr. Larissa Lapteva Center for Biologics Evaluation and Research, FDA, USA

Multidrug resistant tuberculosis (MDR-TB): an update
Dr. Simon Tiberi Queen Mary University of London, UK

Challenging patents: third party observations
Dr. Jonathan D.M. Atkinson Partner HGF Limited and Director, Atkinson IP Consulting Limited, UK

Challenging patents: EPO oppositions and appeals
Dr. Jonathan D.M. Atkinson Partner HGF Limited and Director, Atkinson IP Consulting Limited, UK